BANF1 and neoplasm: Two recent pre-clinical studies have shown that alterations of genes encoding subunits of polymorphic BRG−/BRM-associated factor (BAF) and Polybromo-associated BAF (PBAF) complexes may have an impact on tumor microenvironment and on the capacity of tumors to respond to immune-checkpoint inhibitors (ICI) [1, 2].